← Back to Clinical Trials
Recruiting NCT06381505

NCT06381505 RetracTOR/ Retractor for Image Guided Trans-Oral Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06381505
Status Recruiting
Phase —
Sponsor Ryan J. Halter
Condition Oral Cavity Disease
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2025-02-25
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2025-02-25 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to demonstrate that a polymer retractor functions the same as a standard metal retractor used during endoscopy and throat surgery. The retractor is the device that holds the mouth open so the surgeon can easily access the mouth and throat. For example, this study aims to confirm that the mouth is held open the same amount with a polymer retractor as it is with a metal retractor. Benchtop experiments have demonstrated that the metal and polymer retractor's function the same, and thus this study will use this in patients.

Eligibility Criteria

Inclusion Criteria: 1. Clinical diagnosis or suspected cancer the oral cavity, oropharynx, hypopharynx, or larynx requiring resection. 2. Undergoing staging endoscopy at DHMC 3. Ability to understand and the willingness to sign a written informed consent document. 4. Age ≥ 18 years old 5. For females of child bearing potential, a negative pregnancy evaluation per standard of care. Exclusion Criteria: 1. Prisoners 2. Adults with impaired decision-making capacity 3. Any condition for which, in the opinion of the investigator, contraindicates study participation. 4. Procedures that use high temperature generating devices such as laser \-

Contact & Investigator

Central Contact

Ryan J Halter, PhD

✉ Ryan.J.Halter@dartmouth.edu

📞 603 646-0773

Principal Investigator

Ryan J Halter, PhD

PRINCIPAL INVESTIGATOR

Dartmouth-Hitchcock, Lebanon

Frequently Asked Questions

Who can join the NCT06381505 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Oral Cavity Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06381505 currently recruiting?

Yes, NCT06381505 is actively recruiting participants. Contact the research team at Ryan.J.Halter@dartmouth.edu for enrollment information.

Where is the NCT06381505 trial being conducted?

This trial is being conducted at Lebanon, United States.

Who is sponsoring the NCT06381505 clinical trial?

NCT06381505 is sponsored by Ryan J. Halter. The principal investigator is Ryan J Halter, PhD at Dartmouth-Hitchcock, Lebanon. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology